Tilray
-
Tilray Stock Volatility: Trump Cannabis Policy Speculation Sends TLRY on a Wild Ride
Tilray Brands (TLRY) stock soared and then sharply pulled back as speculation over President Trump’s potential cannabis rescheduling fueled a sector-wide rally, followed by rapid profit-taking amid policy uncertainty.
-
Tilray Stock Soars 28% as Trump Administration Eyes Marijuana Reclassification
Tilray Brands’ stock surged 28% following reports that the Trump administration may loosen federal marijuana restrictions, triggering a broad rally in cannabis stocks and reshaping investor expectations for the sector.
-
Tilray (TLRY) Stock Surges After Q1 Revenue Beat Amid Investor Caution
Tilray’s Q1 earnings surprise fueled a stock rally, but deep financial and industry risks urge investors to tread carefully.
-
Tilray Stock Surges 41% Amid Trump’s CBD Endorsement and Insider Confidence
Tilray’s stock soared 41% after Donald Trump’s public support for CBD and a wave of insider purchases, signaling renewed optimism for the cannabis sector.